EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

N6-methyladenosine modification of 3'tRF-AlaAGC impairs PD-1 blockade efficacy by promoting lactic acid accumulation in the tumor microenvironment of gastric carcinoma

Weiguo Xu, Bin Zhou, Ping Wang, Yuyan Ma, Yu Jiang, Dongping Mo, Jun Wu, Jingjing Ma, Xiao Wang, Yinxing Miao, Yong Nian, Junyu Zheng und 3 weitere

Drug Resistance Updates · 2025-03 · 79 · 101197

DOI: 10.1016/j.drup.2024.101197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2025-03. Verfasst von Weiguo Xu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer R…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Tumor Microenvironment, Adenosine, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jiangsu Commission of Health, Jiangsu Cancer Hospital, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The balance between CD8+ T cells and regulatory T (Treg) cells in the tumor microenvironment (TME) plays a crucial role in the immune checkpoint inhibition (ICI) therapy in gastric carcinoma (GC). However, related factors leading to the disturbance of TME and resistance to ICI therapy remain unknown. In this study, we applied N6-methyladenosine (m6A) small RNA Epitranscriptomic Microarray and screened out 3'tRF-AlaAGC based on its highest differential expression level and lowest inter-group variance. N6-methyladenosine modification significantly enhanced the stability of 3'tRF-AlaAGC, which strengthened glycolysis and lactic acid (LA) production in GC cells by binding to PTBP1 (Polypyrimidine Tract Binding Protein 1). In the peritoneal GC implantation model established in huPBMC-NCG mice, 3'tRF-AlaAGC significantly increased the proportion of PD1+ Treg cells. Furthermore, in high-LA environments driven by glucose consumption of GC cells, Treg cells actively uptake LA through MCT1, facilitating NFAT1 translocation into the nucleus and enhancing PD1 expression, whereas PD1 expression by effector T cell is diminished. Meanwhile, T cell suppression assays were performed under low-LA or high-LA conditions, and the proliferation of CD8+ T cells was dampened by adding Sintilimab in a high-LA but not in a low-LA environment, suggesting the preferential activation of PD1+ Treg cell. These findings deciphered the complexities of the immune microenvironment in GC, providing prospects for identifying robust biomarkers that could improve the evaluation of therapeutic effectiveness and prognosis in immune therapy for GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsTumor MicroenvironmentAdenosineProgrammed Cell Death 1 ReceptorLactic AcidImmune Checkpoint InhibitorsAnimalsMiceHumansCell Line, TumorT-Lymphocytes, RegulatoryPolypyrimidine Tract-Binding ProteinGlycolysis

Stichwörter der Autor:innen

Gastric carcinomaImmunotherapyM6A modificationTsRNATumor microenvironment

Substanzen

AdenosineN-methyladenosineProgrammed Cell Death 1 ReceptorLactic AcidImmune Checkpoint InhibitorsPDCD1 protein, humanPolypyrimidine Tract-Binding Protein

Autor:innen und Institutionen

  • Department of General Surgery, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.
  • Department of Medical Oncology, Shanghai Pulmonary Hospital, Shanghai, China.
  • Department of Clinical Laboratory, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.
  • Department of Clinical Laboratory, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
  • Institute of Agri-products Processing, Jiangsu Academy of Agricultural Sciences, Nanjing, China.
  • Department of Radiology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.

Förderung

  • Jiangsu Commission of Health
  • Jiangsu Cancer Hospital
  • National Natural Science Foundation of China
  • Jiangsu Province Natural Science Foundation

Zitieren

APA

Xu, W., Zhou, B., Wang, P., Ma, Y., Jiang, Y., Mo, D., Wu, J., Ma, J., Wang, X., Miao, Y., Nian, Y., Zheng, J., Li, J., Yan, F., & Li, G. (2025). N6-methyladenosine modification of 3'tRF-AlaAGC impairs PD-1 blockade efficacy by promoting lactic acid accumulation in the tumor microenvironment of gastric carcinoma. Drug Resistance Updates, 79, 101197. https://doi.org/10.1016/j.drup.2024.101197

Vancouver

Xu W, Zhou B, Wang P, Ma Y, Jiang Y, Mo D, et al. N6-methyladenosine modification of 3'tRF-AlaAGC impairs PD-1 blockade efficacy by promoting lactic acid accumulation in the tumor microenvironment of gastric carcinoma. Drug Resistance Updates. 2025;79:101197. doi:10.1016/j.drup.2024.101197

BibTeX
@article{Xu2025,
  author = {Xu, Weiguo and Zhou, Bin and Wang, Ping and Ma, Yuyan and Jiang, Yu and Mo, Dongping and Wu, Jun and Ma, Jingjing and Wang, Xiao and Miao, Yinxing and Nian, Yong and Zheng, Junyu and Li, Jie and Yan, Feng and Li, Gang},
  title = {N6-methyladenosine modification of 3'tRF-AlaAGC impairs PD-1 blockade efficacy by promoting lactic acid accumulation in the tumor microenvironment of gastric carcinoma},
  journal = {Drug Resistance Updates},
  year = {2025},
  volume = {79},
  pages = {101197},
  doi = {10.1016/j.drup.2024.101197}
}
Kostenlos starten →